Evidence map›Paper›PMID 41716973›Full record

ArticleGMS hygiene and infection control2026

Monoclonal outbreak caused by ceftazidime-avibactam resistant bla

Bahise Çağla Taşkın Dalgıç, Elif Seren Tanriverdi, İlayda Budak, Gülgün Yenişehirli, Barış Otlu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in GMS hygiene and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bahise Çağla Taşkın DalgıçMicrobiology Laboratory Unit, Manisa Public Health Laboratory, Manisa, Turkey.
Elif Seren TanriverdiDepartment of Medical Microbiology, Inonu University, Faculty of Medicine, Malatya, Turkey.
İlayda BudakDepartment of Medical Microbiology, Tokat Gaziosmanpasa University, Faculty of Medicine, Tokat, Turkey.
Gülgün YenişehirliDepartment of Medical Microbiology, Tokat Gaziosmanpasa University, Faculty of Medicine, Tokat, Turkey.
Barış OtluDepartment of Medical Microbiology, Inonu University, Faculty of Medicine, Malatya, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to determine the ceftazidime-avibactam susceptibilities and clonal relationships of Methods: Fifteen Results: All 15 Conclusion: This study evaluated an intensive care unit outbreak caused by a clone resistant to CAZ-AVI, which has been reported to have susceptibility rates of up to 100% in OXA-48-producing CRKP isolates and is suggested as first choice therapy. To prevent the spread of CAZ-AVI-resistant CRKP isolates, it is essential to conduct active surveillance studies in hospitals. Especially ICUs - where these strains are common - should be routinely screened. Infection control practices in general must also be tightened.

Indexed as

Carbapenem-resistant K. pneumoniaeceftazidime-avibactamhospital outbreakintensive care unitOXA-48

Identifiers

PMID41716973
PMCPMC12914368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.